Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-04-2024 | Dasatinib | Case report

Dasatinib/Imatinib

Various toxicities

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Nakamura Y, et al. Analysis of drug transporter gene polymorphisms in an elderly patient with chronic myeloid leukemia successfully treated with intermittent low-dose dasatinib. Geriatrics and Gerontology International 23 : 965-966, No. 12, Dec 2023. Available from: URL: https://dx.doi.org/10.1111/ggi.14713 Nakamura Y, et al. Analysis of drug transporter gene polymorphisms in an elderly patient with chronic myeloid leukemia successfully treated with intermittent low-dose dasatinib. Geriatrics and Gerontology International 23 : 965-966, No. 12, Dec 2023. Available from: URL: https://​dx.​doi.​org/​10.​1111/​ggi.​14713
Metadata
Title
Dasatinib/Imatinib
Various toxicities
Publication date
01-04-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-57388-4

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Prednisone

Case report

Temozolomide

Case report

Multiple drugs

Case report

AZD-1222

Case report

Terizidone